Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 3.32 % |
3 Month Return | + 4.99 % |
1 Year Return | + 10.45 % |
Market Stats | |
Previous Close | ₹110.60 |
Open | ₹111.25 |
Volume | 6,770.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹232.70Cr |
P/E Ratio | 11.12 |
PEG Ratio | 9.12 |
Market Cap | ₹232.70 Cr |
P/B Ratio | 1.08 |
EPS | 7.97 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 10.93 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹232.70 Cr | 119.35% | 0.52 | ₹16 Cr | ₹108 Cr | |
NA | ₹44.02 Cr | 1.53% | 0.58 | NA | NA | |
NA | ₹260.52 Cr | 273.93% | 0.58 | -₹12 Cr | ₹15 Cr | |
NA | ₹286.75 Cr | 122.28% | 0.66 | ₹5 Cr | ₹155 Cr | |
NA | ₹15,763.63 Cr | 26.32% | 0.51 | NA | NA |
Organisation | Alpa Laboratories Ltd |
Headquarters | Indore |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Alpa Laboratories Ltd
Alpa Laboratories Limited has a lower P/E ratio than the market despite rapid earnings growth. Shareholders accepting significantly lower selling prices suggest unobserved threats to earnings and potential future volatility.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 3 quarters, 3.55 Cr → 7.69 Cr (in ₹), with an average increase of 32.0% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 0.36% to 0.74% in Sep 2024 quarter
Price Rise
In the last 1 month, ALPA stock has moved up by 3.3%
Revenue Rich
Revenue is up for the last 2 quarters, 26.6 Cr → 31.85 Cr (in ₹), with an average increase of 16.5% per quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 62.6% return, outperforming this stock by 52.2%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 57.29% of holdings in Sep 2024 quarter
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 128.6% return, outperforming this stock by 14.2%
Retail Holding Down
Retail Investor have decreased holdings from 42.35% to 41.96% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 57.29% | 0.00 | |
Foreign Institutions | 0.74% | 107.78 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 41.96% | ||
Others | 0% | 300.00 |
Alpa Laboratories Ltd in the last 5 years
Lowest (7.54x)
October 25, 2021
Today (11.12x)
November 22, 2024
Industry (54.77x)
November 22, 2024
Highest (65.88x)
July 22, 2019
Alpa Laboratories Ltd’s net profit jumped 32.82% since last year same period to ₹7.69Cr in the Q2 2024-2025. On a quarterly growth basis, Alpa Laboratories Ltd has generated 50.78% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Alpa Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.
Alpa Laboratories Ltd (ALPA) share price today is ₹110.78
Alpa Laboratories Ltd is listed on NSE
Alpa Laboratories Ltd is listed on BSE
PE Ratio of Alpa Laboratories Ltd is 11.12
PE ratio = Alpa Laboratories Ltd Market price per share / Alpa Laboratories Ltd Earnings per share
Today’s traded volume of Alpa Laboratories Ltd(ALPA) is 6,770.00.
Today’s market capitalisation of Alpa Laboratories Ltd(ALPA) is ₹232.7Cr.
Alpa Laboratories Ltd(ALPA | Price |
---|---|
52 Week High | ₹144.5 |
52 Week Low | ₹69.9 |
Alpa Laboratories Ltd(ALPA) share price is ₹110.78. It is down -23.34% from its 52 Week High price of ₹144.5
Alpa Laboratories Ltd(ALPA) share price is ₹110.78. It is up 58.48% from its 52 Week Low price of ₹69.9
Alpa Laboratories Ltd(ALPA | Returns |
---|---|
1 Day Returns | 0.18% |
1 Month Returns | 3.32% |
3 Month Returns | 4.99% |
1 Year Returns | 10.45% |